Cannabis advocacy groups in Missouri are raising concerns about new state regulations that restrict the amount of medical marijuana patients can purchase. Andrew Mullins, the executive director of the Missouri Cannabis Trade Association, highlighted these issues during the organization’s annual lobby day, where members discussed the impact of these guidelines on patient access.
Under the current policy, medical marijuana patients face strict caps on their purchase quantities, which some advocates argue may hinder their ability to manage their medical conditions effectively. The Missouri Department of Health and Senior Services has implemented these limits as part of an effort to regulate the state’s medical marijuana program, but critics argue that it undermines the intent of providing adequate care for those in need.
Advocates contend that the caps could disproportionately affect patients who rely on cannabis for chronic pain management or other serious health issues. For example, a patient requiring higher doses for effective relief may find themselves unable to purchase enough product due to these restrictions.
The Missouri Cannabis Trade Association and other organizations are calling for a reevaluation of these regulations, advocating for a more patient-centered approach that considers individual medical needs rather than imposing uniform limits.
As the debate continues, advocates are urging state regulators to engage with medical professionals and patients to develop policies that better support those who depend on cannabis for their health. They emphasize the importance of ensuring that patients have adequate access to the medicine they need without unnecessary barriers.
English 
Spanish 
German 
Czech